- Home
- BHRB vs KOD Comparison
BHRB vs KOD Comparison
Compare BHRB & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHRB | KOD |
|---|---|---|
| Founded | 1852 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 907.7M | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BHRB | KOD |
|---|---|---|
| Price | $66.68 | $24.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $71.67 | $22.29 |
| AVG Volume (30 Days) | 43.9K | ★ 755.0K |
| Earning Date | 01-23-2026 | 11-13-2025 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | ★ 264.64 | N/A |
| EPS | ★ 7.05 | N/A |
| Revenue | ★ $331,643,000.00 | N/A |
| Revenue This Year | $51.05 | N/A |
| Revenue Next Year | $5.90 | N/A |
| P/E Ratio | $9.45 | ★ N/A |
| Revenue Growth | ★ 82.85 | N/A |
| 52 Week Low | $47.57 | $1.92 |
| 52 Week High | $71.75 | $24.99 |
Technical Indicators
Market Signals| Indicator | BHRB | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 67.87 | 67.58 |
| Support Level | $64.07 | $21.24 |
| Resistance Level | $67.75 | $23.63 |
| Average True Range (ATR) | 1.69 | 1.93 |
| MACD | 0.45 | 0.21 |
| Stochastic Oscillator | 86.29 | 90.36 |
Price Performance
Historical ComparisonAbout BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.